comparemela.com

Latest Breaking News On - Jianzhong zhang - Page 3 : comparemela.com

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

SUZHOU, China, March 30, 2023 /PRNewswire/ Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company de.

Hong kongJianzhong zhangKintor pharmaUniversity people hospitalRapid progress on global clinical developmentHong kong listed companiesHong kong stock exchangeInnovation companiesInnovative pharmaceutical companiesMeeting of chinese hair research societyKintor pharmaceuticalPrnewswire kintor pharmaceutical limited pharmaPharmaceutical limitedShanghai hong kong stock connectYouzhi tongGlobal clinical development

Kintor Pharma says alopecia primary endpoint met

Kintor Pharma has announced results of a phase II clinical trial for its potential topical drug to treat adult female androgeneticalopecia.

Kintor pharmaJianzhong zhangKintor pharmaceuticalDepartment of dermatologyUniversity people hospitalKintor pharmaceutical limitedPeking university peopleSavin scale

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826 s Treatment of Female Androgenetic Alopecia in China Was Met

DJ Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met EQS Newswire / 02/12/2022 / 10:34 UTC+8 Kintor

Kintor pharmaJianzhong zhangFinancial pressKintor pharmaceuticalDepartment of dermatologyUniversity people hospitalKintor pharmaceutical limited pharmaPharma announcedPrimary endpointFemale androgenetic alopeciaChina was metPharmaceutical limitedPeking university peopleSavin scaleYouzhi tongChief executive officer

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826 s Treatment of Female Androgenetic Alopecia in China Was Met

/PRNewswire/ Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and.

Kintor pharmaJianzhong zhangKintor pharmaceutical limited kintorpharmaDepartment of dermatologyUniversity people hospitalKintor pharmaceutical limitedPeking university peopleSavin scaleYouzhi tongChief executive officer

Kintor Announces 2022 Interim Results and Recent Business Update

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma" or "the Company", HKEX: 9939), a clinical-stage biotechnology company developing innovative.

United statesHong kongFederation of bosnia and herzegovinaBosnia herzegovinaMacau generalRepublic of ghanaKintor pharmaJianzhong zhangHong kong stock connect programMinistry of healthKintor pharmaceuticalGuangdong provincial department of human resourcesMost influential small molecule innovative drug companiesTechnology innovation support plan for international scienceJiangsu provincial department of scienceTechnology cooperation hong kong

vimarsana © 2020. All Rights Reserved.